(Received 16 November 1960) Ruegg et al. (1959) and Linn et al. (1959) have reported that rat liver contains two ubiquinones with C46 and C50 side chains (coenzymes Q, and Qlo respectively), the former predominating. Experiments in this Laboratory confirmed the presence of both these ubiquinones in our stock-colony rats and also showed the presence of traces of ubiquinones with side chains containing 40 and 35 carbon atoms (Lawson, Mercer, Glover & Morton, 1960) . Similar observations have also been made independently by others (Diplock, Edwin, Green, Bunyan & Marcinkiewicz, 1960) .
The occurrence of at least four ubiquinones in the rat raises the question of their origin. One or more may come from the diet, some components of which are known to contain ubiquinone (Page, Gale, Koniuszy & Folkers, 1959) and others may be formed by intestinal micro-organisms. The similarity between the ubiquinones and vitamins K2 suggests that the rat possibly makes use of a preformed substituted benzoquinone moiety, to which it may attach one of a series of polyisoprenoid units in a manner similar to that claimed by Martius & Esser (1958) for the utilization of 2-methyl-1:4-naphthoquinone in the synthesis of vitamin K2 (with a polyisoprenoid side chain). It has already been shown that [2-14C]mevalonate (Gloor & Wiss, 1959a) and [1-L4C] acetate (Dialameh & Olson, 1959) can be incorporated in vivo into ubiquinone by the rat. The radioactivity was only in the side chain (Wiss, 1959;  Gloor, Schindler & Wise, 1960) so the aromatic nucleusis presumably independently available.
The origin of this substituted quinone portion of the molecule in the animal body is still unknown, although in micro-organisms similar quinones such as aurantiogliocladin (Birch, Fryer & Smith, 1958) and fumigatin (D. E. M. Lawson, N. M. Packter and J. Glover, unpublished observations) have been shown to be derived from [14C] acetate. A number of aromatic compounds have been tested for precursor function. Gloor & Wise (1959a) showed that [3H]methylfumigatin (3:4-dimethoxy-2:5-toluquinone) was not incorporated into ubiquinone in the rat. Again, the nucleus of vitamin E apparently cannot be utilized (Gloor & Wiss, 1959a; Alaupovic & Johnson, 1959) . Further, vitamin E deficiency does not appear to affect the concentration of ubiquinone in rat tissues (Morton & Phillips, 1959) , although more recently results have been obtained which are at variance with this and suggest that ubiquinone levels are lowered (Green, Edwin, .
The aim of the study was to determine the portions of the ubiquinone molecule which can be synthesized by the various tissues of the rat.
Secondly, it would be useful to know if a particular quinone administered orally can be stored unchanged and utilized in the animal or converted into the other homologues. In the present work, [2-14C]acetate was administered intraperitoneally or orally to rats and the specific activities of ubiquinone from intestine, skin and liver were determined. Several experiments have been carried out to measure the incorporation of [2-14C]mevalonate into ubiquinone formed in vitro during incubation for 3-9 hr. of everted intestinal sacs (Wilson & Wiseman, 1954) of the rat. The absorption of ubiquinone-45 administered orally in single doses has been studied in the rat and the effect on endogenous ubiquinone-45 levels of adding ubiquinone-50 to the diet has been explored for rat liver and intestine. EXPERIMENTAL Animals. Hooded rats (average weight 160 g.) from the stock colony were used in all experiments. Females were used in Expts. I, II, III, VIII and IX, and males were used in the remainder. The females normally contain a slightly higher level of ubiquinone in the liver than the males (Hemming, 1958; (Osborne & Mendel, 1913) ; choline chloride, 0-1. Diet no. 2 contained (%): sucrose, 70; casein, 20; arachis oil, 5-4; salt mixture 4-3; synthetic vitamin B mixture, 0-3 (Homer, 1958) . Vitamin A was given in the form of a premix, each rat receiving 80 i.u. per week. This diet was low in ubiquinone-45 and was used for feeding experiments with ubiquinone-50. Ubiquinone could not be detected in the arachis oil, 20 g. of which were saponified and the unsaponified part was chromatographed on alumina as described below.
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D. E. M. LAWSON AND OTHERS Dosing. In Expt. I, three doses of [2-_4C]acetate (10.4 ,o in 0-5 ml. of 0.9% NaCi) were injected intraperitoneally on successive days to each of three rats from the stock colony. In Expt. II, two doses of [2-L4C]acetate (16.4 jh each) dissolved in water, were taken up on a little dry cellulose powder and admixed with about 3 g. of diet no. 1. The mixture was then formed into small pellets which the starving animals ate readily without loss.
The remainder of the daily supply of diet (about 10 g.) was then given to the animals. In Expt. VIII, the absorption and storage of single doses of ubiquinone were examined with nine female rats from the same litter. Each of four in the test group were given 47 mg. of ubiquinone-45 dissolved in a little arachis oil. After 24 hr. the test and five control animals were killed, and their tissues examined for ubiquinone.
During this work the stock diet contained mainly ubiquinone-45, which could have affected the concentration of this homologue in the rat tissues. Therefore, the effect of administering a diet containing predominantly ubiquinone-50 on the concentrations of these two homologues in the rat was examined. The relative amounts of each homologue present in the intestines and liver were estimated after chromatographic separation on paper as described below.
The animals; were killed by a sharp blow on the back of the head and neck 24 hr. after the last dose of ubiquinone or food, and the various tissues excised immediately. Those tissues not analysed right away were stored at -22°until they could be extracted.
Preparation of intestinal 8ac8 and incubation procedure.
The animals used for the preparation of intestinal sacs were starved for a few hours before killing. The intestines were excised and washed out with 0.9% NaCl and everted by the procedure of Wilson & Wiseman (1954) . The lumen was then filled with bicarbonate buffer (Krebs & Henseleit, 1932) with petroleum jelly as the stationary phase by dipping the rolled sheet in a 5% solution in light petioleum and allowing it to drain and dry uniformly. For the quantitative work the petroleum jelly is previously purified by passing a solution in light petroleum through a large column of alumina grade 0 (100 g.). This removed an impurity which absorbs very strongly in the 260 mg region and would interfere with the spectrophotometric assay of the separated ubiquinones when eluted from the paper. A tiny drop of the ubiquinone solution is applied to the paper at the starting point for the qualitative work, but in the quantitative experiments the solution is applied as a narrow band about 4 in. long at the starting line by using a micropipette. The mobile phase is NN-dimethylformamide containing 2 % of water. The spots or zones can be located by ultraviolet light and cut out. The ubiquinones are then eluted with spectroscopically pure ethanol into tubes kept in a closed box. The eluate, usually less than 5 ml., can be made up to a suitable volume for examination in the spectrophotometer.
The results of analyses of (a) synthetic mixtures and (b) fractions of liver unsaponifiable matter by this procedure are given in Table 1 . They show that the recovery is only about 80%. The apparently slightly lower figures for liver fractions are due to the fact that these extracts also contain some ubiquinone-40 and ubiquinone-35 which are not included. The percentage recovery is much the same for both ubiquinone-45 and -50.
Estimation of ubiquinone. The amounts of ubiquinone in the chromatographic fractions were determined spectrophotometrically after correction for irrelevant absorption by the Morton & Stubbs (1946) procedure which has been found highly reliable for chromatography fractions containing not less than 20% of ubiquinone. The extinctions (E) of the extracts in cyclohexane were read at the following three wavelengths: 262 m,g, (E1), 272 mp (E.) and 282 m,u (E,). The equation obtained was E0,. at 272 m,g (A,.)= 2-28(2E2 -El -E,).
The constant 2-28 was derived from the absorption curve of the pure substance determined on the same spectrophotometer as that used in the routine analyses.
Where irrelevant end-absorption was strong but the maximum at 272 m,u was still clear-cut, use was made ofthe procedure described by Pumphrey & Redfearn (1960 The results also show clearly that oral administration of the radioactive acetate yields the labelled terpenoid compounds with a much higher specific activity in the intestine. The tissue ubiquinone and carrier were then isolated and purified chromatographically. The ubiquinone fraction was radioactive, so it was crystallized several times to constant specific activity. The Expts. I-III, with ubiquinone-50 as carrier, were done before it was discovered that ubiquinone-45 is the main homologue in the rat. The drop in radioactivity between the second and third crystallizations was attributed to loss of ubiquinone-45 from the crystallization of the ubiquinone-50 carrier. The later experiments were done with ubiquinone-45 as carrier and no such loss of radioactivity occurred after three crystallizations. The results are given in Table 3 .
In two experiments, however, where ubiquinone carrier was not added at the outset, the reisolated ubiquinone was unlabelled, which agrees with the findings of and Phillips (1960) with rat-liver homogenates. The effect of adding the ubiquinone carrier at the outset of the experiment appears to be significant, although the activity trapped (200 counts/min./mg. or a total of 2 x 10-3 pc) is extremely small in comparison with the amount of [2-14C]mevalonate (10,uc) used. It represents an incorporation of 0-02 %.
Thus it appears that isolated intestinal tissue can synthesize not only the side chain from small intermediary metabolites such as acetate and mevalonate but can also couple it to the nucleus, the source of which is still unknown.
Location of radioactivity in [14C]ubiquinone. In the course of these experiments and parallel work on the absorption of dietary ubiquinone, it was discovered that normal rat liver and intestine contained traces of ubiquinone-40 and -35 respectively in addition to the -45 and -50 homologues previously reported (Ruegg et al. 1959; Linn et al. 1959) . A mixed [14C]ubiquinone specimen diluted with ubiquinone-50 was acetylated and degraded by ozonolysis as described by Morton et al. (1958) , and the products were oxidized further to form laevulinic acid and the ring acid which contains the first two carbon atoms of the side chain.
The laevulinic acid was resolved from the ring acid and isolated as the crystalline 2:4-dinitrophenylhydrazone derivative (Rilling & Bloch, 1959 ). An attempt was made to obtain the aromatic nucleus in a pure form as the S-benzyli8othiouronium salt, but the yield was poor and the substance was not easily crystallized. The laevulinic acid carried the bulk of the activity at 46 000 counts/min./m-mole, whereas the ring compound possessed only 650 counts/min./m-mole, confirming that the main incorporation of radiocarbon occurred in the side chain.
Storage. From the relatively uniform values reported in the literature for the concentration of ubiquinone in various animal tissues, it appears that large reserves are not accumulated in the liver, unlike vitamin A. The capacity of rat tissues to retain even a temporary reserve was exatined in a preliminary experiment VIII, the scale of which wa-s limited by the amount of crystalline ubiquinone-45 available at the time. The ubiquinone contents of various tissues from the group of four dosed females killed 24 hr. after dosing are compared with those of the control group in Table 4 . Only the liver and intestine of the dosed group contained amounts of ubiquinone-45 in excess of the normal. This suggested that a small reserve may be held but the values for the heart and kidney were unexpectedly a little lower in the test than in the control group. The variation is perhaps due to losses in purifying such small amounts. Of the 4-7 mg. administered to each rat only 0-6 mg. or 13 % of the dose was recovered from the tissues 24 hr. later. Thus the degree of absorption is poor or else its rate of metabolism and excretion is high. Koniuszy, Gale, Page & Folkers (1960) , however, have reported that small amounts of ubiquinone are excreted in human urine.
The various ubiquinone fractions from the tissues of the above rats were examined qualitatively by reversed-phase paper chromatography.
Ubiquinone-45 and -50 were observed in every tissue, with the former in considerable excess. In addition, small amounts of ubiquinone-40 and -35 were detected in fractions from liver, kidney and intestine, but not in the heart or skeletal-muscle preparations. It is possible, however, that, since only small quantities of the latter extracts were available for analysis, ubiquinone-40 and -35 concentrations were below the limit of detection.
A quantitative analysis was carried out on the liver ubiquinones of a group of three female rats (about 2 months old) maintained on the stock cube diet. Out of 611 jug. applied to the paper the relative proportions of the three major components estimated, ubiquinone-45, -50 and -40, were 419, 56 and 27 ,ug./liver (av. wt. 5-7 g.) respectively. Ubiquinone-35 was present at a lower level than ubiquinone-40. The recovery of ubiquinone in this analysis was about average (82 %).
Origin of ubiquinone homologue8. In order to check whether the ubiquinone-40 and -35 encountered in rat tissue came from the diet, 10 g. of lipid extract (from approx. 280 g. of powdered food cubes) were saponified for 30 min. in the presence of pyrogallol and in a nitrogen atmosphere. The ubiquinones were isolated from the unsaponifiable matter as described above. The content of total ubiquinones was 0 44 mg./100 g. of diet (uncorrected for slight destruction in the saponification of the lipids). The main component was the -45 homologue with only a little -50. The others were not detected so that the ubiquinone-40 and -35 were synthesized either by the microflora of the intestine or in the rat tissues. The effect of changing the diet on the ubiquinone pattern in the tissues was examined next. In
Expt. IX, five groups of animals were examined at weekly intervals after being placed on diet no. 2 enriched with ubiquinone-50. The proportions of ubiquinone-45 to -50 were measured in the livers of each group and compared with the corresponding values for controls. The results are given in Table 5 . It became apparent as the experiment progressed that the administered ubiquinone-50 was not affecting the level of ubiquinone-45 in the tissues appreciably so the final group 5 was given supplements of 0-33 mg. of ubiquinone-50/rat/day for 3 days before being killed. It is clear from the results that even this relatively high concentration of ubiquinone-50 did not affect the endogenous ubiquinone-45 which tended to remain constant around 130,ug./g. of tissue. Similarly, in the intestine (where the ubiquinone-45 might have been expected to exchange more easily), the same situation was obtained. The values for total ubiquinones in intestinal tissue are given in Table 6 , but the proportion of ubiquinone-45 to -50 was only measured in the last group during the period when ubiquinone-50 intake was optimum. It is quite clear from the absolute values and the ratios found, namely 2-2 (experimental) as against 3-1 (control), that dietary ubiquinone-50 has not affected or replaced the endogenous ubiquinone-45. This does not necessarily mean, however, that a metabolic fragment such as the nucleus of ubiquinone-50 may not be used for the biosynthesis of ubiquinone-45. DISCUSSION Although the total amounts of [14C]acetate administered by different routes to the two groups of rats in vivo were approximately the same, the specific activities of the [14C]ubiquinone isolated from the corresponding organs of the two groups differed widely. The organ or tissue which first received the labelled precursor in highest concentration produced ubiquinone with the greatest specific activity. The intestine had the ubiquinone with highest specific activity in both experiments, reflecting its high rate of metabolism. It is Table 4 . Ab8orption of single do8es of ubiquinone-45 by the rat Expt. VIII: nine female rats from the same litter were divided into two groups of five (controls) and four (test). Ubiquinone-45 (4-7 mg.) was administered as a single dose in arachis oil to each rat in the test group, 24 hr. before it was killed. Ratio 10-2 9.9 10*1 9'6 9.9 3.4 2-6 2-7 1.1 1*7 * These values are corrected for the slight loss of material in the chromatographic separation.
t Each rat in group 5 was given a supplement of ubiquinone-50 (1 mg./day) for 3 days before it was killed. of Gloor & Wiss (1959a) . The turnover rate of the isoprenoid side chain of ubiquinone must therefore be very much slower than that of cholesterol. Presumably it is elaborated in the form of the pyrophosphate in a manner similar to that for farnesyl pyrophosphate and nerolidyl pyrophosphate (Lynen, Eggerer, Henning & Kessel, 1958; Goodman & Popjak, 1960 of Gloor & Wiss (1959a) indicates that the preformed nucleus in the form of 3:4-dimethoxy-2:5-toluquinone cannot be used for the biosynthesis so some modified structure must be found.
The incorporation of the small but significant amount of [2-14C] (Pennock, Hemming & Morton, 1960) . The size of side chain coupled to the quinone nucleus is probably controlled by the specificity of the particular enzyme in the organism under study.
The results for the administration of ubiquinone-45 and -50 to rats (Tables 4 and 5) indicate that a little storage of ubiquinone takes place in the liver but probably at a site different from that of the endogenous ubiquinone-45, since the concentration of the latter is not appreciably affected by the administration of ubiquinone-50 (see Table 5 ). Yet during this period of 5 weeks the level of ubiquinone-50 in the liver rose steadily from an average level of 13 ,ug./g. to 124 ug./g. In the intestine, the ubiquinone-45 level also remains very steady despite the transit of much more ubiquinone-50 across the gut wall. These observations lead to the conclusion that dietary ubiquinone-50 does not easily replace the endogenous material, which is found mainly in the mitochondria and it may be stored elsewhere in the cell.
The ratio of ubiquinone-45 to -50 in the livers of the control rats on the synthetic diet (low in ubiquinones) was approximately 9-9:1, which is a little higher than that found by Gloor & Wiss (1959b but much higher than the values 5-0-5-6 observed by Olson & Dialameh (1960) and 2-2-3-0 obtained by for normal and vitamin A-deficient rats. Our own stockcolony rats on the food cubes known to contain mainly ubiquinone-45 show a ratio in the region of 7-5:1. These differences should probably be attributed more to dietary effects than to intestinal flora or variations of strain.
In the control groups of rats (see Tables 5 and 6 ) the ratio for the liver is quite different from the ratio (between 2:1 and 3: 1) for the intestine.
Possibly each tissue manufactures its own characteristic proportion as it is known to do with the sterols. Unlike the latter, however, dietary ubiquinone does not appear to affect the synthesis of the endogenous material. 
